Latest News

Estimate of COVID-19 seroprevalence in the US suggests few in the population developed antibodies in the first wave



Researchers from Stanford University explain that patients on dialysis represent an important population to study general COVID-19 seroprevalence. These patients already undergo routine, monthly laboratory studies and represent similar risk factors to contracting COVID-19 as the general population, including age, non-white race, and poverty. Unlike community-based surveys, where a select group may show up for or agree to be tested and require a significant on-the-ground effort to launch, patients on dialysis are amenable to random sampling as part of their routine care.

Source link

Related posts

STAT Plus: Startup Spotlight: This Cambridge biotech snagged a deal with Roche without ever making a pitch

Newsemia

Components of pharmacist-led discharge counseling vary

Newsemia

Desert bush spider toxin helps researchers to better understand human and insect biology

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World